Imaging News

SAN DIEGO — Establishing mandatory competencies for musculoskeletal ultrasound is necessary to improve its use in both rheumatology residency programs and clinical practice, a speaker said at ACR Convergence 2023.

SAN DIEGO — Monitoring of rheumatoid arthritis-associated interstitial lung disease remains highly variable and “suboptimal” in the real world, according to a speaker at ACR Convergence 2023.

Patients with suspected giant cell arteritis should undergo an ultrasound as the first-line imaging method, according to updated EULAR recommendations published in the Annals of the Rheumatic Diseases.

A fully automated, machine learning model that predicts bone marrow edema in sacroiliac joint MRI could improve screening for spondyloarthritis and decrease diagnostic delay, according to data published in Arthritis & Rheumatology.

SAN DIEGO — Imaging and symptom rating scales offer physicians ample opportunity to follow patients with suspected myositis and “tease out” fast vs. slow progressors, noted a speaker at the 2023 Congress of Clinical Rheumatology West.

MRI and PET scans are viable alternatives to ultrasound for cranial arteries in patients with suspected giant cell arteritis, according to a 2023 update of EULAR’s recommendations for imaging in large vessel vasculitis.

As many as 41% of patients who are 1 year postpartum meet the ASAS criteria for sacroiliitis, which could lead to false positive diagnoses of axial spondyloarthritis, according to data published in Arthritis & Rheumatology.

Methotrexate use at the pre-arthritis stage of symptoms and subclinical inflammation fails to prevent clinical arthritis, but does improve symptoms and MRI-detected inflammation vs. placebo, according to data published in The Lancet.

LOUISVILLE, Ky. — Persistent, chronic inflammation seen in moderate to severe psoriasis is associated with plaque destabilization and rupture that drives MI, and biologic treatment can reduce CV risk, according to a speaker.

ORLANDO, Fla. — Many patients with non-radiographic axial spondyloarthritis experience symptoms for nearly a decade before receiving a diagnosis, according to a presenter at the 2022 Rheumatology Nurses Society Conference.